(UPDATED) Coronary intravascular lithotripsy shows promise for improving the ability to optimize PCI in severely calcified lesions, with good safety and efficacy out to 30 days, according to data from ...
(UPDATED) In stable CAD patients, using intravascular lithotripsy to break up superficial or deep calcium and pave the way for stent implantation results in good outcomes to 1 year, with low rates of ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Boston Scientific Corporation (NYSE: BSX) today announced positive results from the pivotal FRACTURE Investigational Device ...
Please provide your email address to receive an email when new articles are posted on . Shockwave Medical announced its intravascular lithotripsy system received premarket approval from the FDA for ...
Moderate-to-severe coronary calcification continues to complicate PCI by impairing stent delivery/expansion and increasing risks such as dissection and under-expansion. SEISMIQ 4CE uses balloon-based ...
POWER CAD I study will evaluate feasibility of the Pulse IVL™ system in patients with severely calcified coronary arterial disease Amplitude Vascular Systems (AVS), a medical device company recently ...
Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed, investigational system that aims to fracture hardened calcium within the ...
Late-breaking data from global pivotal study achieved high rates of freedom from major adverse cardiac events and procedural success in patients with severe coronary artery disease MARLBOROUGH, Mass.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results